Table of Content

1 Sickle Cell Disease Drug Market Overview
1.1 Sickle Cell Disease Drug Product Overview
1.2 Sickle Cell Disease Drug Market Segment by Type
1.2.1 ARQ-092
1.2.2 BIVV-003
1.2.3 CAL-H
1.2.4 CTX-001
1.2.5 DRX-194
1.2.6 Others
1.3 Global Sickle Cell Disease Drug Market Size by Type
1.3.1 Global Sickle Cell Disease Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Sickle Cell Disease Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Sickle Cell Disease Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Sickle Cell Disease Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Sickle Cell Disease Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Sickle Cell Disease Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Sickle Cell Disease Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Sickle Cell Disease Drug Sales Breakdown by Type (2018-2024)
2 Global Sickle Cell Disease Drug Market Competition by Company
2.1 Global Top Players by Sickle Cell Disease Drug Sales (2018-2024)
2.2 Global Top Players by Sickle Cell Disease Drug Revenue (2018-2024)
2.3 Global Top Players by Sickle Cell Disease Drug Price (2018-2024)
2.4 Global Top Manufacturers Sickle Cell Disease Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Sickle Cell Disease Drug Market Competitive Situation and Trends
2.5.1 Sickle Cell Disease Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Sickle Cell Disease Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sickle Cell Disease Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Sickle Cell Disease Drug Market
2.8 Key Manufacturers Sickle Cell Disease Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Sickle Cell Disease Drug Status and Outlook by Region
3.1 Global Sickle Cell Disease Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Sickle Cell Disease Drug Historic Market Size by Region
3.2.1 Global Sickle Cell Disease Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Sickle Cell Disease Drug Sales in Value by Region (2018-2024)
3.2.3 Global Sickle Cell Disease Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Sickle Cell Disease Drug Forecasted Market Size by Region
3.3.1 Global Sickle Cell Disease Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Sickle Cell Disease Drug Sales in Value by Region (2024-2034)
3.3.3 Global Sickle Cell Disease Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Sickle Cell Disease Drug by Application
4.1 Sickle Cell Disease Drug Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Sickle Cell Disease Drug Market Size by Application
4.2.1 Global Sickle Cell Disease Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Sickle Cell Disease Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Sickle Cell Disease Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Sickle Cell Disease Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Sickle Cell Disease Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Sickle Cell Disease Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Sickle Cell Disease Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Sickle Cell Disease Drug Sales Breakdown by Application (2018-2024)
5 North America Sickle Cell Disease Drug by Country
5.1 North America Sickle Cell Disease Drug Historic Market Size by Country
5.1.1 North America Sickle Cell Disease Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Sickle Cell Disease Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Sickle Cell Disease Drug Sales in Value by Country (2018-2024)
5.2 North America Sickle Cell Disease Drug Forecasted Market Size by Country
5.2.1 North America Sickle Cell Disease Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Sickle Cell Disease Drug Sales in Value by Country (2024-2034)
6 Europe Sickle Cell Disease Drug by Country
6.1 Europe Sickle Cell Disease Drug Historic Market Size by Country
6.1.1 Europe Sickle Cell Disease Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Sickle Cell Disease Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Sickle Cell Disease Drug Sales in Value by Country (2018-2024)
6.2 Europe Sickle Cell Disease Drug Forecasted Market Size by Country
6.2.1 Europe Sickle Cell Disease Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Sickle Cell Disease Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Sickle Cell Disease Drug by Region
7.1 Asia-Pacific Sickle Cell Disease Drug Historic Market Size by Region
7.1.1 Asia-Pacific Sickle Cell Disease Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Sickle Cell Disease Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Sickle Cell Disease Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Sickle Cell Disease Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Sickle Cell Disease Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Sickle Cell Disease Drug Sales in Value by Region (2024-2034)
8 Latin America Sickle Cell Disease Drug by Country
8.1 Latin America Sickle Cell Disease Drug Historic Market Size by Country
8.1.1 Latin America Sickle Cell Disease Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Sickle Cell Disease Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Sickle Cell Disease Drug Sales in Value by Country (2018-2024)
8.2 Latin America Sickle Cell Disease Drug Forecasted Market Size by Country
8.2.1 Latin America Sickle Cell Disease Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Sickle Cell Disease Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Sickle Cell Disease Drug by Country
9.1 Middle East and Africa Sickle Cell Disease Drug Historic Market Size by Country
9.1.1 Middle East and Africa Sickle Cell Disease Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Sickle Cell Disease Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Sickle Cell Disease Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Sickle Cell Disease Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Sickle Cell Disease Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Sickle Cell Disease Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Acceleron Pharma Inc
10.1.1 Acceleron Pharma Inc Company Information
10.1.2 Acceleron Pharma Inc Introduction and Business Overview
10.1.3 Acceleron Pharma Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Acceleron Pharma Inc Sickle Cell Disease Drug Products Offered
10.1.5 Acceleron Pharma Inc Recent Development
10.2 Addmedica SAS
10.2.1 Addmedica SAS Company Information
10.2.2 Addmedica SAS Introduction and Business Overview
10.2.3 Addmedica SAS Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Addmedica SAS Sickle Cell Disease Drug Products Offered
10.2.5 Addmedica SAS Recent Development
10.3 Angiocrine Bioscience Inc
10.3.1 Angiocrine Bioscience Inc Company Information
10.3.2 Angiocrine Bioscience Inc Introduction and Business Overview
10.3.3 Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Angiocrine Bioscience Inc Sickle Cell Disease Drug Products Offered
10.3.5 Angiocrine Bioscience Inc Recent Development
10.4 Annexin Pharmaceuticals AB
10.4.1 Annexin Pharmaceuticals AB Company Information
10.4.2 Annexin Pharmaceuticals AB Introduction and Business Overview
10.4.3 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Products Offered
10.4.5 Annexin Pharmaceuticals AB Recent Development
10.5 ArQule Inc
10.5.1 ArQule Inc Company Information
10.5.2 ArQule Inc Introduction and Business Overview
10.5.3 ArQule Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 ArQule Inc Sickle Cell Disease Drug Products Offered
10.5.5 ArQule Inc Recent Development
10.6 Bio Products Laboratory Ltd
10.6.1 Bio Products Laboratory Ltd Company Information
10.6.2 Bio Products Laboratory Ltd Introduction and Business Overview
10.6.3 Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Bio Products Laboratory Ltd Sickle Cell Disease Drug Products Offered
10.6.5 Bio Products Laboratory Ltd Recent Development
10.7 Bioverativ Inc
10.7.1 Bioverativ Inc Company Information
10.7.2 Bioverativ Inc Introduction and Business Overview
10.7.3 Bioverativ Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Bioverativ Inc Sickle Cell Disease Drug Products Offered
10.7.5 Bioverativ Inc Recent Development
10.8 bluebird bio Inc
10.8.1 bluebird bio Inc Company Information
10.8.2 bluebird bio Inc Introduction and Business Overview
10.8.3 bluebird bio Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 bluebird bio Inc Sickle Cell Disease Drug Products Offered
10.8.5 bluebird bio Inc Recent Development
10.9 Bristol-Myers Squibb Co
10.9.1 Bristol-Myers Squibb Co Company Information
10.9.2 Bristol-Myers Squibb Co Introduction and Business Overview
10.9.3 Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Bristol-Myers Squibb Co Sickle Cell Disease Drug Products Offered
10.9.5 Bristol-Myers Squibb Co Recent Development
10.10 Calimmune Inc
10.10.1 Calimmune Inc Company Information
10.10.2 Calimmune Inc Introduction and Business Overview
10.10.3 Calimmune Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Calimmune Inc Sickle Cell Disease Drug Products Offered
10.10.5 Calimmune Inc Recent Development
10.11 CRISPR Therapeutics
10.11.1 CRISPR Therapeutics Company Information
10.11.2 CRISPR Therapeutics Introduction and Business Overview
10.11.3 CRISPR Therapeutics Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 CRISPR Therapeutics Sickle Cell Disease Drug Products Offered
10.11.5 CRISPR Therapeutics Recent Development
10.12 CSL Ltd
10.12.1 CSL Ltd Company Information
10.12.2 CSL Ltd Introduction and Business Overview
10.12.3 CSL Ltd Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 CSL Ltd Sickle Cell Disease Drug Products Offered
10.12.5 CSL Ltd Recent Development
10.13 Daiichi Sankyo Co Ltd
10.13.1 Daiichi Sankyo Co Ltd Company Information
10.13.2 Daiichi Sankyo Co Ltd Introduction and Business Overview
10.13.3 Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Products Offered
10.13.5 Daiichi Sankyo Co Ltd Recent Development
10.14 Editas Medicine Inc
10.14.1 Editas Medicine Inc Company Information
10.14.2 Editas Medicine Inc Introduction and Business Overview
10.14.3 Editas Medicine Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Editas Medicine Inc Sickle Cell Disease Drug Products Offered
10.14.5 Editas Medicine Inc Recent Development
10.15 Errant Gene Therapeutics LLC
10.15.1 Errant Gene Therapeutics LLC Company Information
10.15.2 Errant Gene Therapeutics LLC Introduction and Business Overview
10.15.3 Errant Gene Therapeutics LLC Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Errant Gene Therapeutics LLC Sickle Cell Disease Drug Products Offered
10.15.5 Errant Gene Therapeutics LLC Recent Development
10.16 Gamida Cell Ltd
10.16.1 Gamida Cell Ltd Company Information
10.16.2 Gamida Cell Ltd Introduction and Business Overview
10.16.3 Gamida Cell Ltd Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Gamida Cell Ltd Sickle Cell Disease Drug Products Offered
10.16.5 Gamida Cell Ltd Recent Development
10.17 Genethon SA
10.17.1 Genethon SA Company Information
10.17.2 Genethon SA Introduction and Business Overview
10.17.3 Genethon SA Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Genethon SA Sickle Cell Disease Drug Products Offered
10.17.5 Genethon SA Recent Development
10.18 Gilead Sciences Inc
10.18.1 Gilead Sciences Inc Company Information
10.18.2 Gilead Sciences Inc Introduction and Business Overview
10.18.3 Gilead Sciences Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Gilead Sciences Inc Sickle Cell Disease Drug Products Offered
10.18.5 Gilead Sciences Inc Recent Development
10.19 Global Blood Therapeutics Inc
10.19.1 Global Blood Therapeutics Inc Company Information
10.19.2 Global Blood Therapeutics Inc Introduction and Business Overview
10.19.3 Global Blood Therapeutics Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Global Blood Therapeutics Inc Sickle Cell Disease Drug Products Offered
10.19.5 Global Blood Therapeutics Inc Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Sickle Cell Disease Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Sickle Cell Disease Drug Industrial Chain Analysis
11.4 Sickle Cell Disease Drug Market Dynamics
11.4.1 Sickle Cell Disease Drug Industry Trends
11.4.2 Sickle Cell Disease Drug Market Drivers
11.4.3 Sickle Cell Disease Drug Market Challenges
11.4.4 Sickle Cell Disease Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Sickle Cell Disease Drug Distributors
12.3 Sickle Cell Disease Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of ARQ-092
Table 2. Major Company of BIVV-003
Table 3. Major Company of CAL-H
Table 4. Major Company of CTX-001
Table 5. Major Company of DRX-194
Table 6. Major Company of Others
Table 7. Global Sickle Cell Disease Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Sickle Cell Disease Drug Sales by Type (2018-2024) & (K Pcs)
Table 9. Global Sickle Cell Disease Drug Sales Market Share in Volume by Type (2018-2024)
Table 10. Global Sickle Cell Disease Drug Sales by Type (2018-2024) & (US& Million)
Table 11. Global Sickle Cell Disease Drug Market Share in Value by Type (2018-2024)
Table 12. Global Sickle Cell Disease Drug Price by Type (2018-2024) & (USD/Pcs)
Table 13. Global Sickle Cell Disease Drug Sales by Type (2024-2034) & (K Pcs)
Table 14. Global Sickle Cell Disease Drug Sales Market Share in Volume by Type (2024-2034)
Table 15. Global Sickle Cell Disease Drug Sales by Type (2024-2034) & (US$ Million)
Table 16. Global Sickle Cell Disease Drug Sales Market Share in Value by Type (2024-2034)
Table 17. Global Sickle Cell Disease Drug Price by Type (2024-2034) & (USD/Pcs)
Table 18. North America Sickle Cell Disease Drug Sales by Type (2018-2024) & (K Pcs)
Table 19. North America Sickle Cell Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 20. Europe Sickle Cell Disease Drug Sales (K Pcs) by Type (2018-2024)
Table 21. Europe Sickle Cell Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Asia-Pacific Sickle Cell Disease Drug Sales (K Pcs) by Type (2018-2024)
Table 23. Asia-Pacific Sickle Cell Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Latin America Sickle Cell Disease Drug Sales (K Pcs) by Type (2018-2024)
Table 25. Latin America Sickle Cell Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 26. Middle East and Africa Sickle Cell Disease Drug Sales (K Pcs) by Type (2018-2024)
Table 27. Middle East and Africa Sickle Cell Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 28. Global Sickle Cell Disease Drug Sales by Company (2018-2024) & (K Pcs)
Table 29. Global Sickle Cell Disease Drug Sales Share by Company (2018-2024)
Table 30. Global Sickle Cell Disease Drug Revenue by Company (2018-2024) & (US$ Million)
Table 31. Global Sickle Cell Disease Drug Revenue Share by Company (2018-2024)
Table 32. Global Market Sickle Cell Disease Drug Price by Company (2018-2024) & (USD/Pcs)
Table 33. Global Sickle Cell Disease Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 34. Global Sickle Cell Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 35. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sickle Cell Disease Drug as of 2022)
Table 36. Date of Key Manufacturers Enter into Sickle Cell Disease Drug Market
Table 37. Key Manufacturers Sickle Cell Disease Drug Product Type
Table 38. Mergers & Acquisitions, Expansion Plans
Table 39. Global Sickle Cell Disease Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 40. Global Sickle Cell Disease Drug Sales by Region (2018-2024) & (K Pcs)
Table 41. Global Sickle Cell Disease Drug Sales Market Share in Volume by Region (2018-2024)
Table 42. Global Sickle Cell Disease Drug Sales by Region (2018-2024) & (US$ Million)
Table 43. Global Sickle Cell Disease Drug Sales Market Share in Value by Region (2018-2024)
Table 44. Global Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 45. Global Sickle Cell Disease Drug Sales by Region (2024-2034) & (K Pcs)
Table 46. Global Sickle Cell Disease Drug Sales Market Share in Volume by Region (2024-2034)
Table 47. Global Sickle Cell Disease Drug Sales by Region (2024-2034) & (US$ Million)
Table 48. Global Sickle Cell Disease Drug Sales Market Share in Value by Region (2024-2034)
Table 49. Global Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 50. Global Sickle Cell Disease Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 51. Global Sickle Cell Disease Drug Sales by Application (2018-2024) & (K Pcs)
Table 52. Global Sickle Cell Disease Drug Sales Market Share in Volume by Application (2018-2024)
Table 53. Global Sickle Cell Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 54. Global Sickle Cell Disease Drug Sales Market Share in Value by Application (2018-2024)
Table 55. Global Sickle Cell Disease Drug Price by Application (2018-2024) & (USD/Pcs)
Table 56. Global Sickle Cell Disease Drug Sales by Application (2024-2034) & (K Pcs)
Table 57. Global Sickle Cell Disease Drug Sales Market Share in Volume by Application (2024-2034)
Table 58. Global Sickle Cell Disease Drug Sales by Application (2024-2034) & (US$ Million)
Table 59. Global Sickle Cell Disease Drug Sales Market Share in Value by Application (2024-2034)
Table 60. Global Sickle Cell Disease Drug Price by Application (2024-2034) & (USD/Pcs)
Table 61. North America Sickle Cell Disease Drug Sales by Application (2018-2024) (K Pcs)
Table 62. North America Sickle Cell Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 63. Europe Sickle Cell Disease Drug Sales by Application (2018-2024) (K Pcs)
Table 64. Europe Sickle Cell Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 65. Asia-Pacific Sickle Cell Disease Drug Sales by Application (2018-2024) (K Pcs)
Table 66. Asia-Pacific Sickle Cell Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 67. Latin America Sickle Cell Disease Drug Sales by Application (2018-2024) (K Pcs)
Table 68. Latin America Sickle Cell Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 69. Middle East and Africa Sickle Cell Disease Drug Sales by Application (2018-2024) (K Pcs)
Table 70. Middle East and Africa Sickle Cell Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 71. North America Sickle Cell Disease Drug Sales by Country (2018-2024) & (K Pcs)
Table 72. North America Sickle Cell Disease Drug Sales Market Share in Volume by Country (2018-2024)
Table 73. North America Sickle Cell Disease Drug Sales by Country (2018-2024) & (US$ Million)
Table 74. North America Sickle Cell Disease Drug Sales Market Share in Value by Country (2018-2024)
Table 75. North America Sickle Cell Disease Drug Sales by Country (2024-2034) & (K Pcs)
Table 76. North America Sickle Cell Disease Drug Sales Market Share in Volume by Country (2024-2034)
Table 77. North America Sickle Cell Disease Drug Sales by Country (2024-2034) & (US$ Million)
Table 78. North America Sickle Cell Disease Drug Sales Market Share in Value by Country (2024-2034)
Table 79. Europe Sickle Cell Disease Drug Sales by Country (2018-2024) & (K Pcs)
Table 80. Europe Sickle Cell Disease Drug Sales Market Share in Volume by Country (2018-2024)
Table 81. Europe Sickle Cell Disease Drug Sales by Country (2018-2024) & (US$ Million)
Table 82. Europe Sickle Cell Disease Drug Sales Market Share in Value by Country (2018-2024)
Table 83. Europe Sickle Cell Disease Drug Sales by Country (2024-2034) & (K Pcs)
Table 84. Europe Sickle Cell Disease Drug Sales Market Share in Volume by Country (2024-2034)
Table 85. Europe Sickle Cell Disease Drug Sales by Country (2024-2034) & (US$ Million)
Table 86. Europe Sickle Cell Disease Drug Sales Market Share in Value by Country (2024-2034)
Table 87. Asia-Pacific Sickle Cell Disease Drug Sales by Region (2018-2024) & (K Pcs)
Table 88. Asia-Pacific Sickle Cell Disease Drug Sales Market Share in Volume by Region (2018-2024)
Table 89. Asia-Pacific Sickle Cell Disease Drug Sales by Region (2018-2024) & (US$ Million)
Table 90. Asia-Pacific Sickle Cell Disease Drug Sales Market Share in Value by Region (2018-2024)
Table 91. Asia-Pacific Sickle Cell Disease Drug Sales by Region (2024-2034) & (K Pcs)
Table 92. Asia-Pacific Sickle Cell Disease Drug Sales Market Share in Volume by Region (2024-2034)
Table 93. Asia-Pacific Sickle Cell Disease Drug Sales by Region (2024-2034) & (US$ Million)
Table 94. Asia-Pacific Sickle Cell Disease Drug Sales Market Share in Value by Region (2024-2034)
Table 95. Latin America Sickle Cell Disease Drug Sales by Country (2018-2024) & (K Pcs)
Table 96. Latin America Sickle Cell Disease Drug Sales Market Share in Volume by Country (2018-2024)
Table 97. Latin America Sickle Cell Disease Drug Sales by Country (2018-2024) & (US$ Million)
Table 98. Latin America Sickle Cell Disease Drug Sales Market Share in Value by Country (2018-2024)
Table 99. Latin America Sickle Cell Disease Drug Sales by Country (2024-2034) & (K Pcs)
Table 100. Latin America Sickle Cell Disease Drug Sales Market Share in Volume by Country (2024-2034)
Table 101. Latin America Sickle Cell Disease Drug Sales by Country (2024-2034) & (US$ Million)
Table 102. Latin America Sickle Cell Disease Drug Sales Market Share in Value by Country (2024-2034)
Table 103. Middle East and Africa Sickle Cell Disease Drug Sales by Country (2018-2024) & (K Pcs)
Table 104. Middle East and Africa Sickle Cell Disease Drug Sales Market Share in Volume by Country (2018-2024)
Table 105. Middle East and Africa Sickle Cell Disease Drug Sales by Country (2018-2024) & (US$ Million)
Table 106. Middle East and Africa Sickle Cell Disease Drug Sales Market Share in Value by Country (2018-2024)
Table 107. Middle East and Africa Sickle Cell Disease Drug Sales by Country (2024-2034) & (K Pcs)
Table 108. Middle East and Africa Sickle Cell Disease Drug Sales Market Share in Volume by Country (2024-2034)
Table 109. Middle East and Africa Sickle Cell Disease Drug Sales by Country (2024-2034) & (US$ Million)
Table 110. Middle East and Africa Sickle Cell Disease Drug Sales Market Share in Value by Country (2024-2034)
Table 111. Acceleron Pharma Inc Company Information
Table 112. Acceleron Pharma Inc Introduction and Business Overview
Table 113. Acceleron Pharma Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 114. Acceleron Pharma Inc Sickle Cell Disease Drug Product
Table 115. Acceleron Pharma Inc Recent Development
Table 116. Addmedica SAS Company Information
Table 117. Addmedica SAS Introduction and Business Overview
Table 118. Addmedica SAS Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 119. Addmedica SAS Sickle Cell Disease Drug Product
Table 120. Addmedica SAS Recent Development
Table 121. Angiocrine Bioscience Inc Company Information
Table 122. Angiocrine Bioscience Inc Introduction and Business Overview
Table 123. Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 124. Angiocrine Bioscience Inc Sickle Cell Disease Drug Product
Table 125. Angiocrine Bioscience Inc Recent Development
Table 126. Annexin Pharmaceuticals AB Company Information
Table 127. Annexin Pharmaceuticals AB Introduction and Business Overview
Table 128. Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 129. Annexin Pharmaceuticals AB Sickle Cell Disease Drug Product
Table 130. Annexin Pharmaceuticals AB Recent Development
Table 131. ArQule Inc Company Information
Table 132. ArQule Inc Introduction and Business Overview
Table 133. ArQule Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 134. ArQule Inc Sickle Cell Disease Drug Product
Table 135. ArQule Inc Recent Development
Table 136. Bio Products Laboratory Ltd Company Information
Table 137. Bio Products Laboratory Ltd Introduction and Business Overview
Table 138. Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 139. Bio Products Laboratory Ltd Sickle Cell Disease Drug Product
Table 140. Bio Products Laboratory Ltd Recent Development
Table 141. Bioverativ Inc Company Information
Table 142. Bioverativ Inc Introduction and Business Overview
Table 143. Bioverativ Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 144. Bioverativ Inc Sickle Cell Disease Drug Product
Table 145. Bioverativ Inc Recent Development
Table 146. bluebird bio Inc Company Information
Table 147. bluebird bio Inc Introduction and Business Overview
Table 148. bluebird bio Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 149. bluebird bio Inc Sickle Cell Disease Drug Product
Table 150. bluebird bio Inc Recent Development
Table 151. Bristol-Myers Squibb Co Company Information
Table 152. Bristol-Myers Squibb Co Introduction and Business Overview
Table 153. Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 154. Bristol-Myers Squibb Co Sickle Cell Disease Drug Product
Table 155. Bristol-Myers Squibb Co Recent Development
Table 156. Calimmune Inc Company Information
Table 157. Calimmune Inc Introduction and Business Overview
Table 158. Calimmune Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 159. Calimmune Inc Sickle Cell Disease Drug Product
Table 160. Calimmune Inc Recent Development
Table 161. CRISPR Therapeutics Company Information
Table 162. CRISPR Therapeutics Introduction and Business Overview
Table 163. CRISPR Therapeutics Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 164. CRISPR Therapeutics Sickle Cell Disease Drug Product
Table 165. CRISPR Therapeutics Recent Development
Table 166. CSL Ltd Company Information
Table 167. CSL Ltd Introduction and Business Overview
Table 168. CSL Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 169. CSL Ltd Sickle Cell Disease Drug Product
Table 170. CSL Ltd Recent Development
Table 171. Daiichi Sankyo Co Ltd Company Information
Table 172. Daiichi Sankyo Co Ltd Introduction and Business Overview
Table 173. Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 174. Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Product
Table 175. Daiichi Sankyo Co Ltd Recent Development
Table 176. Editas Medicine Inc Company Information
Table 177. Editas Medicine Inc Introduction and Business Overview
Table 178. Editas Medicine Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 179. Editas Medicine Inc Sickle Cell Disease Drug Product
Table 180. Editas Medicine Inc Recent Development
Table 181. Errant Gene Therapeutics LLC Company Information
Table 182. Errant Gene Therapeutics LLC Introduction and Business Overview
Table 183. Errant Gene Therapeutics LLC Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 184. Errant Gene Therapeutics LLC Sickle Cell Disease Drug Product
Table 185. Errant Gene Therapeutics LLC Recent Development
Table 186. Gamida Cell Ltd Company Information
Table 187. Gamida Cell Ltd Introduction and Business Overview
Table 188. Gamida Cell Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 189. Gamida Cell Ltd Sickle Cell Disease Drug Product
Table 190. Gamida Cell Ltd Recent Development
Table 191. Genethon SA Company Information
Table 192. Genethon SA Introduction and Business Overview
Table 193. Genethon SA Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 194. Genethon SA Sickle Cell Disease Drug Product
Table 195. Genethon SA Recent Development
Table 196. Gilead Sciences Inc Company Information
Table 197. Gilead Sciences Inc Introduction and Business Overview
Table 198. Gilead Sciences Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 199. Gilead Sciences Inc Sickle Cell Disease Drug Product
Table 200. Gilead Sciences Inc Recent Development
Table 201. Global Blood Therapeutics Inc Company Information
Table 202. Global Blood Therapeutics Inc Introduction and Business Overview
Table 203. Global Blood Therapeutics Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 204. Global Blood Therapeutics Inc Sickle Cell Disease Drug Product
Table 205. Global Blood Therapeutics Inc Recent Development
Table 206. Key Raw Materials Lists
Table 207. Raw Materials Key Suppliers Lists
Table 208. Sickle Cell Disease Drug Market Trends
Table 209. Sickle Cell Disease Drug Market Drivers
Table 210. Sickle Cell Disease Drug Market Challenges
Table 211. Sickle Cell Disease Drug Market Restraints
Table 212. Sickle Cell Disease Drug Distributors List
Table 213. Sickle Cell Disease Drug Downstream Customers
Table 214. Research Programs/Design for This Report
Table 215. Key Data Information from Secondary Sources
Table 216. Key Data Information from Primary Sources
List of Figures
Figure 1. Sickle Cell Disease Drug Product Picture
Figure 2. Global Sickle Cell Disease Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Sickle Cell Disease Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Sickle Cell Disease Drug Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of ARQ-092
Figure 6. Global ARQ-092 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of BIVV-003
Figure 8. Global BIVV-003 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of CAL-H
Figure 10. Global CAL-H Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of CTX-001
Figure 12. Global CTX-001 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of DRX-194
Figure 14. Global DRX-194 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Product Picture of Others
Figure 16. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 17. Global Sickle Cell Disease Drug Sales by Type (2018-2034) & (US$ Million)
Figure 18. Global Sickle Cell Disease Drug Sales Market Share by Type in 2022 & 2034
Figure 19. North America Sickle Cell Disease Drug Sales Market Share in Volume by Type in 2022
Figure 20. North America Sickle Cell Disease Drug Sales Market Share in Value by Type in 2022
Figure 21. Europe Sickle Cell Disease Drug Sales Market Share in Volume by Type in 2022
Figure 22. Europe Sickle Cell Disease Drug Sales Market Share in Value by Type in 2022
Figure 23. Asia-Pacific Sickle Cell Disease Drug Sales Market Share in Volume by Type in 2022
Figure 24. Asia-Pacific Sickle Cell Disease Drug Sales Market Share in Value by Type in 2022
Figure 25. Latin America Sickle Cell Disease Drug Sales Market Share in Volume by Type in 2022
Figure 26. Latin America Sickle Cell Disease Drug Sales Market Share in Value by Type in 2022
Figure 27. Middle East and Africa Sickle Cell Disease Drug Sales Market Share in Volume by Type in 2022
Figure 28. Middle East and Africa Sickle Cell Disease Drug Sales Market Share in Value by Type in 2022
Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by Sickle Cell Disease Drug Sales in 2022
Figure 30. The 5 and 10 Largest Manufacturers in the World: Market Share by Sickle Cell Disease Drug Revenue in 2022
Figure 31. Sickle Cell Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Product Picture of Hospital
Figure 33. Global Hospital Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Clinic
Figure 35. Global Clinic Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Product Picture of Others
Figure 37. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 38. Global Sickle Cell Disease Drug Sales by Application (2018-2034) & (US$ Million)
Figure 39. Global Sickle Cell Disease Drug Sales Market Share by Application in 2022 & 2034
Figure 40. North America Sickle Cell Disease Drug Sales Market Share in Volume by Application in 2022
Figure 41. North America Sickle Cell Disease Drug Sales Market Share in Value by Application in 2022
Figure 42. Europe Sickle Cell Disease Drug Sales Market Share in Volume by Application in 2022
Figure 43. Europe Sickle Cell Disease Drug Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Sickle Cell Disease Drug Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Sickle Cell Disease Drug Sales Market Share in Value by Application in 2022
Figure 46. Latin America Sickle Cell Disease Drug Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Sickle Cell Disease Drug Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Sickle Cell Disease Drug Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Sickle Cell Disease Drug Manufacturing Cost Structure
Figure 51. Sickle Cell Disease Drug Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed